This may be (Nu)Generex, but the major catalysts remain the same; significant progress in uplisting to NASDAQ or NYSE and clarification of non-toxic funding. It's a little early for us to get earnings info, but evidence of real money coming into the coffers during this quarter will also help to stabilize the pps. Given MMPJoe's performance during the last CC, I am confident he is well-prepared to address the above, the acquisitions, and creating the MSO. The recent drop in the pps shows that Mr. Market is not going to cut GNBT any slack. She has to produce and rid herself of all the selfish pigs that want to eat her (our) lunch.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links